Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evgeny Kiselev

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 4, 2015
Interfacial inhibitorsYves Pommier, Evgeny Kiselev, Christophe Marchand
Tetrahedron Letters|September 20, 2011
An unexpected synthesis of 3,5-diaryl-1,2,4-thiadiazoles from thiobenzamides and methyl bromocyanoacetateAbdelrahman S Mayhoub, Evgeny Kiselev, Mark Cushman
Journal of Medicinal Chemistry|February 15, 2012
Azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents: a systematic study of structure-activity relationshipsEvgeny Kiselev, Keli Agama, Yves Pommier, et al.
Bioorganic & Medicinal Chemistry|April 15, 2015
Molecular modeling of the human P2Y14 receptor: A template for structure-based design of selective agonist ligandsKevin Trujillo, Silvia Paoletta, Evgeny Kiselev, et al.
Journal of Medicinal Chemistry|November 25, 2010
Design, synthesis, and evaluation of dibenzo[c,h][1,6]naphthyridines as topoisomerase I inhibitors and potential anticancer agentsEvgeny Kiselev, Thomas S Dexheimer, Yves Pommier, et al.
Journal of Medicinal Chemistry|February 8, 2014
Optimization of the lactam side chain of 7-azaindenoisoquinoline topoisomerase I inhibitors and mechanism of action studies in cancer cellsEvgeny Kiselev, Dhriti Sooryakumar, Keli Agama, et al.
The Journal of Organic Chemistry|May 17, 2012
Dibenzo[c,h][1,5]naphthyridinediones as topoisomerase I inhibitors: design, synthesis, and biological evaluationEvgeny Kiselev, Nicholas Empey, Keli Agama, et al.
DNA Repair|November 28, 2019
Novel deazaflavin tyrosyl-DNA phosphodiesterase 2 (TDP2) inhibitorsEvgeny Kiselev, Azhar Ravji, Jayakanth Kankanala, et al.
Biochemical Pharmacology|May 24, 2014
Probing biased/partial agonism at the G protein-coupled A(2B) adenosine receptorZhan-Guo Gao, Ramachandran Balasubramanian, Evgeny Kiselev, et al.
DNA Repair|May 11, 2018
Probing the evolutionary conserved residues Y204, F259, S400 and W590 that shape the catalytic groove of human TDP1 for 3'- and 5'-phosphodiester-DNA bond cleavageEvgeny Kiselev, Thomas S Dexheimer, Christophe Marchand, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|August 4, 2015
Interfacial inhibitorsYves Pommier, Evgeny Kiselev, Christophe Marchand
Tetrahedron Letters|September 20, 2011
An unexpected synthesis of 3,5-diaryl-1,2,4-thiadiazoles from thiobenzamides and methyl bromocyanoacetateAbdelrahman S Mayhoub, Evgeny Kiselev, Mark Cushman
Journal of Medicinal Chemistry|February 15, 2012
Azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents: a systematic study of structure-activity relationshipsEvgeny Kiselev, Keli Agama, Yves Pommier, et al.
Bioorganic & Medicinal Chemistry|April 15, 2015
Molecular modeling of the human P2Y14 receptor: A template for structure-based design of selective agonist ligandsKevin Trujillo, Silvia Paoletta, Evgeny Kiselev, et al.
Journal of Medicinal Chemistry|November 25, 2010
Design, synthesis, and evaluation of dibenzo[c,h][1,6]naphthyridines as topoisomerase I inhibitors and potential anticancer agentsEvgeny Kiselev, Thomas S Dexheimer, Yves Pommier, et al.
Journal of Medicinal Chemistry|February 8, 2014
Optimization of the lactam side chain of 7-azaindenoisoquinoline topoisomerase I inhibitors and mechanism of action studies in cancer cellsEvgeny Kiselev, Dhriti Sooryakumar, Keli Agama, et al.
The Journal of Organic Chemistry|May 17, 2012
Dibenzo[c,h][1,5]naphthyridinediones as topoisomerase I inhibitors: design, synthesis, and biological evaluationEvgeny Kiselev, Nicholas Empey, Keli Agama, et al.
DNA Repair|November 28, 2019
Novel deazaflavin tyrosyl-DNA phosphodiesterase 2 (TDP2) inhibitorsEvgeny Kiselev, Azhar Ravji, Jayakanth Kankanala, et al.
Biochemical Pharmacology|May 24, 2014
Probing biased/partial agonism at the G protein-coupled A(2B) adenosine receptorZhan-Guo Gao, Ramachandran Balasubramanian, Evgeny Kiselev, et al.
DNA Repair|May 11, 2018
Probing the evolutionary conserved residues Y204, F259, S400 and W590 that shape the catalytic groove of human TDP1 for 3'- and 5'-phosphodiester-DNA bond cleavageEvgeny Kiselev, Thomas S Dexheimer, Christophe Marchand, et al.
Pageof 4